PHASE II CLINICAL TRIAL, TESTING THE EFFICACY OF A HUMANIZED MONOCLONAL ANTIBODY AGAINST THE LEWIS-Y ANTIGEN (LE Y)

Authors

  • Laura Testa Instituto do Câncer do Estado de São Paulo
  • Ruffo Freitas-Junior Universidade Federal de Goiás
  • Sergio V Serrano Hospital de Câncer de Barretos
  • Roberto J Arai Instituto do Câncer do Estado de São Paulo
  • Marina C Zorzetto Hospital de Câncer de Barretos
  • Oren Maletz Recepta Biopharma
  • Max S Mano Instituto do Câncer do Estado de São Paulo
  • Paulo M Hoff Instituto do Câncer do Estado de São Paulo

Downloads

Download data is not yet available.

Author Biographies

Laura Testa, Instituto do Câncer do Estado de São Paulo

Instituto do Câncer do Estado de São Paulo – São Paulo (SP), Brazil. Hospital Sírio Libanês

Marina C Zorzetto, Hospital de Câncer de Barretos

Hospital de Câncer de Barretos – Barretos (SP), Brazil. Recepta Biopharma

Paulo M Hoff, Instituto do Câncer do Estado de São Paulo

Instituto do Câncer do Estado de São Paulo – São Paulo (SP), Brazil. Hospital Sírio Libanês

Downloads

Published

2018-06-07

How to Cite

Testa, L., Freitas-Junior, R., Serrano, S. V., Arai, R. J., Zorzetto, M. C., Maletz, O., … Hoff, P. M. (2018). PHASE II CLINICAL TRIAL, TESTING THE EFFICACY OF A HUMANIZED MONOCLONAL ANTIBODY AGAINST THE LEWIS-Y ANTIGEN (LE Y). Mastology, 28, 11. Retrieved from https://revistamastology.emnuvens.com.br/revista/article/view/621

Issue

Vol. 28 (2018): Supplement 1

Section

Oral

License

Copyright (c) 2018 Laura Testa, Ruffo Freitas-Junior, Sergio V Serrano, Roberto J Arai, Marina C Zorzetto, Oren Maletz, Max S Mano, Paulo M Hoff

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.